KRYS:NASDAQ, Krystal Biotech, Inc.
KRYS stock overview
Krystal Biotech, Inc. (KRYS:NASDAQ) closed at $305.23 on November 13, 2026,
down 0.15% on the day.
The stock trades 20.2% below its 52-week high of $382.54
and 54.1% above its 52-week low of $198.02.
Over the past year, it gained 48.1%.
Krystal Biotech, Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
Key figures
- Price
- $305.23
- Day change
- -0.15%
- Volume
- 109,685
- Average volume
- 282,837
- Market cap
- 9B+
- 52-week range
- $198.02 – $382.54
- 50-day average
- $328.09
- 200-day average
- $309.58
Price action over the past year
In 252 trading sessions since November 13, 2025, KRYS closed higher on 133 days (53%).
Its best day was May 4, 2026 (+7.86%) and its worst was November 2, 2026 (-10.95%).
The stock moved 10% or more in a single session 1 time.
Recent signals
KRYS news
-
Nov 10, 2026:
Krystal Biotech to Present at Upcoming Investor Conferences
-
Nov 3, 2026:
Krystal Biotech (KRYS) Stock Stays Above Fair Value After Buyback Plan
-
Nov 3, 2026:
Earnings Beat May Change The Case For Krystal Biotech (KRYS) Stock
-
Nov 3, 2026:
Is Krystal Biotech (KRYS) Undervalued On Earnings, Buybacks, And Vyjuvek Growth?
-
Nov 3, 2026:
Krystal Biotech Sinks 11% Despite Q3 Beat as Eye Trial Enrollment “Progressed Slower Than Initially Anticipated”
-
Nov 2, 2026:
Krystal Biotech Inc (KRYS) (Q3 2026) Earnings Call Highlights: Vyjuvek Revenue Jumps 30% to ...
-
Nov 2, 2026:
Krystal Biotech, Inc. Q3 2026 Earnings Call Summary
-
Nov 2, 2026:
Krystal Biotech (KRYS) Q3 2026 Earnings Call Transcript
About Krystal Biotech, Inc.
Krystal Biotech Inc is a biopharmaceutical company. It uses gene therapy treatments for patients suffering from rare debilitating disorders.
Similar stocks
Find more stocks like KRYS with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.